Seizure Management in Prehospital Settings Reducing Time to Definitive Care in Epileptic Emergencies
DOI:
https://doi.org/10.22399/ijcesen.4085Keywords:
Status Epilepticus, Prehospital Care, Emergency Medical Services, Seizure Management, Time-to-Treatment, BenzodiazepinesAbstract
Seizure management in prehospital settings plays a critical role in reducing the time to definitive care for patients experiencing epileptic emergencies. Rapid recognition and appropriate intervention by first responders can significantly influence patient outcomes. In such situations, timely administration of anticonvulsant medications, along with proper airway management and monitoring of vital signs, is essential. Training first responders in the identification of different seizure types and their respective management protocols can enhance the efficiency of care provided on-site. Moreover, the integration of advanced communication systems allows paramedics to relay critical patient information to receiving hospitals, ensuring that neurology teams are prepared for immediate intervention upon arrival. Furthermore, the implementation of standardized protocols and guidelines for seizure management in prehospital settings can streamline the response to epileptic emergencies. These protocols should encompass the use of evidence-based practices, such as the administration of benzodiazepines for prolonged seizures, and the establishment of clear pathways for transporting patients to specialized care facilities. Collaboration between emergency medical services (EMS) and hospitals can facilitate continuous education and training, ensuring that all personnel are equipped with the latest knowledge and skills. By prioritizing swift and effective prehospital care, the healthcare system can significantly mitigate the risks associated with prolonged seizures, ultimately improving patient prognosis and quality of life.
References
1. Tanigawa K., Tanaka K. Emergency medical service systems in Japan: past, present, and future. Resuscitation. 2006;69(3):365–370. doi: 10.1016/j.resuscitation.2006.04.001.
2. Sh in S.D., Kitamura T., Hwang S.S., Kajino K., Song K.J., Ro Y.S., et al. Association between resuscitation time interval at the scene and neurological outcome after out-of-hospital cardiac arrest in two Asian cities. Resuscitation. 2014;85(2):203–210. doi: 10.1016/j.resuscitation.2013.10.021.
3. Jaffe E., Strugo R., Bin E., Blustein O., Rosenblat I., Alpert E.A., et al. The role of emergency medical services in containing COVID-19. Am J Emerg Med. 2020;38(7):1526–1527. doi: 10.1016/j.ajem.2020.04.023.
4. Kim H.S., Jang T.C., Kim G.M., Lee S.H., Ko S.H., Seo Y.W. Impact of the coronavirus disease 2019 outbreak on the transportation of patients requiring emergency care. Medicine (Baltimore) 2020;99(50):e23446. doi: 10.1097/MD.0000000000023446.
5. Al Amiry A., Maguire B.J. Emergency medical services (EMS) calls during COVID-19: early lessons learned for systems planning (a narrative review) Open Access Emerg Med. 2021;13:407–414. doi: 10.2147/OAEM.S324568.
6. Zachrison KS, Nielsen VM, de la Ossa NP, Madsen TE, Cash RE, Crowe RP, et al. Prehospital stroke care part 1: emergency medical services and the stroke systems of care. Stroke 2022; Epub ahead of print.
7. Morita T., Tsubokura M., Furutani T., Nomura S., Ochi S., Leppold C., et al. Impacts of the 2011 Fukushima nuclear accident on emergency medical service times in Soma District, Japan: a retrospective observational study. BMJ Open. 2016;6(9):e013205. doi: 10.1136/bmjopen-2016-013205.
8. Tanigawa K., Tanaka K. Emergency medical service systems in Japan: past, present, and future. Resuscitation. 2006;69(3):365–370. doi: 10.1016/j.resuscitation.2006.04.001.
9. Gauss T., Ageron F.X., Devaud M.L., Debaty G., Travers S., Garrigue D., et al. Association of prehospital time to in-hospital trauma mortality in a physician-staffed emergency medicine system. JAMA Surg. 2019;154(12):1117–1124. doi: 10.1001/jamasurg.2019.3475.
10. Neshige S., Aoki S., Takebayashi Y., Shishido T., Yamazaki Y., Iida K., et al. A longitudinal seizure outcome following the COVID-19 pandemic in 2020 and 2021: transient exacerbation or sustainable mitigation. J Neurol Sci. 2022;434 doi: 10.1016/j.jns.2021.120100.
11. Fountain N.B., Van Ness P.C., Bennett A., Absher J., Patel A.D., Sheth K.N., et al. Quality improvement in neurology: Epilepsy Update Quality Measurement Set. Neurology. 2015;84(14):1483–1487. doi: 10.1212/WNL.0000000000001448.
12. Jaffe E., Strugo R., Bin E., Blustein O., Rosenblat I., Alpert E.A., et al. The role of emergency medical services in containing COVID-19. Am J Emerg Med. 2020;38(7):1526–1527. doi: 10.1016/j.ajem.2020.04.023.
13. Neshige S., Aoki S., Takebayashi Y., Shishido T., Yamazaki Y., Iida K., et al. A longitudinal seizure outcome following the COVID-19 pandemic in 2020 and 2021: transient exacerbation or sustainable mitigation. J Neurol Sci. 2022;434 doi: 10.1016/j.jns.2021.120100.
14. The 53rd meeting of Novel Coronavirus Response Headquarters. 2021; Available from: https: //www.kantei.go.jp/jp/singi/novel_coronavirus/th_siryou/sidai_r030122.pdf.
15. Beghi E., Carpio A., Forsgren L., Hesdorffer D.C., Malmgren K., Sander J.W., et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia. 2010;51(4):671–675. doi: 10.1111/j.1528-1167.2009.02285.x.
16. The 2nd Meeting of Subcommittee on Novel Coronavirus Disease Control. 2021; Available from: https://www.cas.go.jp/jp/seisaku/ful/taisakusuisin/bunkakai/dai2/kansensaikakudaiboushi_shihyou_teigen.pdf.
17. S ummary of the Hiroshima City Fire Service Bureau. 2022 September 13, 2022; Available from: https://www.city.hiroshima.lg.jp/site/shobo/12062.html.
18. The summary of the declaration of the state of emergency. 2023; Available from: https://corona.go.jp/news/news_20200421_70.html.
19. Keane S., 25 years of advances in the definition, classification and treatment of status epilepticus. Seizure. 2017;44:65–73. doi: 10.1016/j.seizure.2016.11.001.
20. Copeland J., Epidemiological profile of emergency medical services in Japan: a population-based descriptive study in 2016. Acute Med Surg. 2020;7(1):e485. doi: 10.1002/ams2.485.
21. The 103rd Meeting of the Advisory Board on Countermeasures to COVID-19 Infections. 2022; Available from: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00395.html.
22. Spaite D.W., Valenzuela T.D., Meislin H.W., Criss E.A., Hinsberg P. Prospective validation of a new model for evaluating emergency medical services systems by in-field observation of specific time intervals in prehospital care. Ann Emerg Med. 1993;22(4):638–645. doi: 10.1016/S0196-0644(05)81840-2.
23. Nakao S., Katayama Y., Kitamura T., Hirose T., Sado J., Ishida K., et al. Epidemiological profile of emergency medical services in Japan: a population-based descriptive study in 2016. Acute Med Surg. 2020;7(1):e485. doi: 10.1002/ams2.485.
24. Summary of the confirmed cases for a patient with COVID-19 in Hiroshima city. 2023 January 10, 2023; Available from: https://www.city.hiroshima.lg.jp/site/shobo/12062.html.
25. Annual review Hiroshima City Fire Service Bureau. 2022 November 1, 2022; Available from: https://www.city.hiroshima.lg.jp/site/shobo/list1809-3710.html.
26. The 103rd Meeting of the Advisory Board on Countermeasures to COVID-19 Infections. 2022; Available from: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00395.html.
27. Summary of the Hiroshima City Fire Service Bureau. 2022 September 13, 2022; Available from: https://www.city.hiroshima.lg.jp/site/shobo/12062.html.
28. Trinka E., Cock H., Hesdorffer D. A definition and classification of status epilepticus—Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56:1515–1523. doi: 10.1111/epi.13121.
29. Meldrum B., Horton R. Physiology of status epilepticus in primates. Arch. Neurol. 1973;28:1–9. doi: 10.1001/archneur.1973.00490190019001.
30. DeLorenzo R., Hauser W., Towne A. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996;46:1029–1035. doi: 10.1212/WNL.46.4.1029.
31. Jallon P., Coeytaux A., Galobardes B., Morabia A. Incidence and case-fatality rate of status epilepticus in the Canton of Geneva. Lancet. 1999;353:1496. doi: 10.1016/S0140-6736(99)00583-8.
32. Coeytaux A., Jallon P., Galobardes B., Morabia A. Incidence of status epilepticus in french-speaking Switzerland (EPISTAR). Neurology. 2000;55:693–697. doi: 10.1212/WNL.55.5.693.
33. Wu Y., Shek D., Garcia P., Zhao S., Johnston S. Incidence and mortality of generalized convulsive status epilepticus in California. Neurology. 2002;58:1070–1076. doi: 10.1212/WNL.58.7.1070.
34. Hesdorffer D., Logroscino G., Cascino G., Annegers J., Hauser W. Incidence of status epilepticus in Rochester, Minnesota, 1965–1984. Neurology. 1998;50:735–741. doi: 10.1212/WNL.50.3.735.
35. Betjemann J., Josephson S., Lowenstein D., Burke J. Trends in status epilepticus-related hospitalizations and mortality: Redefined in US practice over time. JAMA Neurol. 2015;72:650–655. doi: 10.1001/jamaneurol.2015.0188.
36. Rossetti A., Logroscino G., Milligan T., Michaelides C., Ruffieux C., Bromfield E. Status epilepticus severity score (STESS): A tool to orient early treatment strategy. J. Neurol. 2008;255:1561–1566. doi: 10.1007/s00415-008-0989-1.
37. Sutter R., Kaplan P., Ruegg S. Independent external validation of the status epilepticus severity score. Crit. Care Med. 2013;41:475–484. doi: 10.1097/CCM.0b013e31829eca06.
38. Michael G., O’Connor R. The diagnosis and management of seizures and status epilepticus in the prehospital setting. Emerg. Med. Clin. N. Am. 2011;29:29–39. doi: 10.1016/j.emc.2010.08.003.
39. Silbergleit R., Durkalski V., Lowenstein D. Intramuscular versus intravenous therapy for prehospital status epilepticus. N. Engl. J. Med. 2012;366:591–600. doi: 10.1056/NEJMoa1107494.
40. Delgado-Escueta A., Wasterlain C., Treiman D., Porter R. Current concepts in neurology: Management of status epilepticus. N. Engl. J. Med. 1982;306:1337–1340. doi: 10.1056/NEJM198206033062205.
41. Lowenstein D.H., Alldredge B.K. Status epilepticus. N. Engl. J. Med. 1998;388:970–976. doi: 10.1056/NEJM199804023381407.
42. Labeled item: The epidemology of status epilepticus in the United States. Dham B., Hunter K., Rincon F. Neurocrit. Care. 2014;20:476–483. doi: 10.1007/s12028-013-9935-x.
43. Jallon P., Morabia A. Incidence of status epilepticus in french-speaking Switzerland (EPISTAR). Neurology. 2000;55:693–697. doi: 10.1212/WNL.55.5.693.
44. Roppolo L., Walters K. Airway management in neurological emergencies. Neurocrit. Care. 2004;1:405–414. doi: 10.1385/NCC:1:4:405.
45. Stone B.J., Chantler P.J., Baskett P.J. The incidence of regurgitation during cardiopulmonary resuscitation: A comparison between the bag valve mask and laryngeal mask airway. Resuscitation. 1998;38:3–6. doi: 10.1016/S0300-9572(98)00068-9.
46. Trinka E., Kälviäinen R. 25 years of advances in the definition, classification and treatment of status epilepticus. Seizure. 2017;44:65–73. doi: 10.1016/j.seizure.2016.11.001.
47. Jaffe E., Strugo R., Bin E., Blustein O., Rosenblat I., Alpert E.A., et al. The role of emergency medical services in containing COVID-19. Am J Emerg Med. 2020;38(7):1526–1527. doi: 10.1016/j.ajem.2020.04.023.
48. Al Amiry A., Maguire B.J. Emergency medical services (EMS) calls during COVID-19: early lessons learned for systems planning (a narrative review) Open Access Emerg Med. 2021;13:407–414. doi: 10.2147/OAEM.S324568.
49. The epidemiology of status epilepticus in the United States. Neshige S., Aoki S., Takebayashi Y., Shishido T., Yamazaki Y., Iida K., et al. J Neurol Sci. 2022;434. doi: 10.1016/j.jns.2021.120100.
50. Dham B., Hunter K., Rincon F. The epidemiology of status epilepticus in the United States. Neurocrit. Care. 2014;20:476–483. doi: 10.1007/s12028-013-9935-x.
51. Beghi E., Carpio A., Forsgren L., Hesdorffer D.C., Malmgren K., Sander J.W., et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia. 2010;51(4):671–675. doi: 10.1111/j.1528-1167.2009.02285.x.
52. Treiman DM, Walton NY, Kendrick C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res. 1990 Jan-Feb;5(1):49–60. doi: 10.1016/0920-1211(90)90065-4. PMID: 2303022. [DOI] [PubMed] [Google Scholar]
53. Chin R.F., Neville B.G., Peckham C., Bedford H., Wade A., Scott R.C. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet. 2006 Jul 15;368(9531):222–229. doi: 10.1016/S0140-6736(06)69043-0. [DOI] [PubMed] [Google Scholar]
54. DeLorenzo R.J., Towne A.R., Pellock J.M., Ko D. Status epilepticus in children, adults, and the elderly. Epilepsia. 1992;33:15–25. doi: 10.1111/j.1528-1157.1992.tb06223.x. [DOI] [PubMed] [Google Scholar]
55. Goldberg E.M., Coulter D.A. Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction. Nat Rev Neurosci. 2013;14(5):337–349. doi: 10.1038/nrn3482. [DOI] [PMC free article] [PubMed] [Google Scholar]
56. Pitkänen A., Lukasiuk K. Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol. 2011 Feb;10(2):173–186. doi: 10.1016/S1474-4422(10)70310-0. [DOI] [PubMed] [Google Scholar]
57. Nordli D.R., Moshé S.L., Shinnar S., Hesdorffer D.C., Sogawa Y., Pellock J.M., et al. Acute EEG findings in children with febrile status epilepticus: results of the FEBSTAT study. Neurology. 2012 Nov 27;79(22):2180–2186. doi: 10.1212/WNL.0b013e3182759766. [DOI] [PMC free article] [PubMed] [Google Scholar]
58. Elaboration: Sutter R., Kaplan P., Ruegg S. Independent external validation of the status epilepticus severity score. Crit. Care Med. 2013;41:475–484. doi: 10.1097/CCM.0b013e31829eca06. [DOI] [PubMed] [Google Scholar]
59. Shorvon S. Status epilepticus: its clinical features and treatment in children and adults. 1994 Jul 21. Cambridge University Press. [cited 2021 Jul 24]; Available from: https://www.cambridge.org/core/books/status-epilepticus/5D31AA6CC71423D394000ABEBF906CD0
60. Dham B., Hunter K., Rincon F. The epidemiology of status epilepticus in the United States. Neurocrit Care. 2014;20:476–483. doi: 10.1007/s12028-013-9935-x. [DOI] [PubMed] [Google Scholar]
61. Treiman DM, Walton NY, Kendrick C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res. 1990;5(1):49–60. doi: 10.1016/0920-1211(90)90065-4.
62. Kapur J., Elm J., Chamberlain J.M., Barsan W., Cloyd J., Lowenstein D., et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019;381(22). doi: 10.1056/NEJMoa1905795. [DOI] [PMC free article] [PubMed] [Google Scholar]
63. Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, et al. Operational classification of seizure types by the international league against epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522–530. 10.1111/epi.13670 [DOI] [PubMed] [Google Scholar]
64. NICE . Epilepsies: diagnosis and management, Clin Guidel [CG137]. 2016. Available from: https://www.nice.org.uk/guidance/cg137
65. Beghi E, Giussani G, Nichols E, Abd‐Allah F, Abdela J, Abdelalim A, et al. Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(4):357–375. 10.1016/S1474-4422(18)30454-X [DOI] [PMC free article] [PubMed] [Google Scholar]
66. Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512–521. 10.1111/epi.13709 [DOI] [PMC free article] [PubMed] [Google Scholar]
67. Elger CE, Hoppe C. Diagnostic challenges in epilepsy: seizure under‐reporting and seizure detection. Lancet Neurol. 2018;17(3):279–288. 10.1016/S1474-4422(18)30038-3 [DOI] [PubMed] [Google Scholar]
68. Mefford HC. Clinical genetic testing in epilepsy. Epilepsy Curr. 2015;15(4):197–201. 10.5698/1535-7511-15.4.197 [DOI] [PMC free article] [PubMed] [Google Scholar]
69. Krumholz A, Wiebe S, Gronseth GS, Gloss DS, Sanchez AM, Kabir AA, et al. Evidence‐based guideline: management of an unprovoked first seizure in adults: report of the guideline development Subcommittee of the American Academy of neurology and the American Epilepsy Society. Epilepsy Curr. 2015;15(3):144–152. 10.5698/1535-7597-15.3.144 [DOI] [PMC free article] [PubMed] [Google Scholar]
70. Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475–482. 10.1111/epi.12550 [DOI] [PubMed] [Google Scholar]
71. Scottish Intercollegiate Guidelines Network , “Guideline 81: diagnosis and management of epilepsies in children and young people,” NHS Qual Improv Scotl, pp. 1–48, 2005. Available from: http://www.sign.ac.uk/guidelines/fulltext/81/index.html. [Google Scholar]
72. NICE . Epilepsies in children, young people and adults. NICE guideline. [NG217]. 2022. Available from: https://www.nice.org.uk/guidance/ng217/resources/epilepsies‐in‐children‐young‐people‐and-adults‐pdf‐66143780239813
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 International Journal of Computational and Experimental Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
